supp.fit

Beta-Carotene: study protocols

291 study groups say how much Beta-Carotene participants took a day. These are the doses the studies gave. They are not a recommendation.

Beta-Carotene: what the research found →

Dose per serving from products

239 products in our catalogue print how much Beta-Carotene a serving holds.

Most common: 1 mg to 2.5 mg, 25% of 239 products.

Dose per servingProducts
50 mcg or less
10
50 mcg to 100 mcg
5
100 mcg to 250 mcg
1
250 mcg to 500 mcg
28
500 mcg to 1 mg
38
1 mg to 2.5 mg
60
2.5 mg to 5 mg
48
5 mg to 10 mg
25
10 mg to 25 mg
9
25 mg to 50 mg
7
over 50 mg
8

Dose per serving from research

283 study groups in 193 studies say how much Beta-Carotene participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 10 mg to 25 mg, 43% of 283 study groups.

Daily doseStudy groups
1 mg or less
11
1 mg to 2.5 mg
15
2.5 mg to 5 mg
12
5 mg to 10 mg
45
10 mg to 25 mg
122
25 mg to 50 mg
58
50 mg to 100 mg
11
over 100 mg
9

Commonly used together

167 of 291 study groups took Beta-Carotene with something else. Shown: what 3 or more different studies gave. The 10 most common of 17.

What was given together, not what works together.

Taken withStudy groups
Vitamin E
120
Vitamin C
98
Zinc
37
Selenium
30
Vitamin A
29
Copper
9
Folic Acid
8
Lycopene
6
Iron
5
Vitamin D
5

291 study groups

Study
The effect of β-carotene on the mortality of male smokers is modified by smoking and by vitamins C and E: evidence against a uniform effect of nutrient
2020 · β-Carotene (BC) · Male smokers aged 50–69 years who smoked at least 5 cigarettes per day at entry
20 mg2227 days14,564
Vitamin A and cancer prevention II: comparison of the effects of retinol and beta-carotene
1998 · beta-carotene · Former blue asbestos workers at high risk of asbestos-related disease
30 mg1826 days512
Beta-carotene produces sustained remissions in patients with oral leukoplakia: results of a multicenter prospective trial
1999 · Continued beta-carotene therapy · Responders with oral leukoplakia after six months of beta-carotene treatment
60 mg1 year11
Double blind, cluster randomised trial of low dose supplementation with vitamin A or beta carotene on mortality related to pregnancy in Nepal. The NNIPS-2 Study Group
1999 · beta carotene · Married women of reproductive age in rural Nepal; some became pregnant during the study
6 mg1278 days—
The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers
1999 · beta-carotene (BC) · middle-aged male smokers
20 mg——
Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma
1999 · beta-carotene supplementation · U.S. male physicians aged 40–84 years; primary prevention of cancer
25 mg438 days—
Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers
2000 · beta-carotene · Men aged 50 to 69 who smoked cigarettes and had no history of stroke
20 mg6 years—
Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States)
2000 · beta-carotene · US male physicians; baseline age and health condition not specified
25 mg——
Vitamin E and beta carotene supplementation in high risk for stroke: a subgroup analysis of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
2000 · beta carotene · Men aged 50–69 who smoked and were included in the high-risk-for-stroke subgroup analysis; a reported subgroup had greater alcohol consumption
20 mg6 years—
A randomized trial of beta carotene and age-related cataract in US physicians
2003 · beta carotene · Male US physicians aged 40 to 84 years; healthy men
25 mg438 days—
The effect of folic acid on the development of stomach and other gastrointestinal cancers
2003 · Natural beta-carotene (N-betaC) · Patients with atrophic gastritis; age and sex not reported
30 mg2 years—
Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study
2004 · beta-carotene · men aged 50–69 who smoked
20 mg8 years—
Effects of alpha-tocopherol and beta-carotene supplementation on upper aerodigestive tract cancers in a large, randomized controlled trial
2007 · beta-carotene only · Male smokers aged 50–69 years, free of cancer at baseline
20 mg2227 days—
A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study
2007 · Beta-carotene group · Women aged 40 years or older with a history of cardiovascular disease or at least three cardiovascular risk factors
25 mg3431 days—
Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake
2008 · Beta-carotene · Males aged 50–69 years who smoked at baseline and had no tuberculosis diagnosis before randomisation
20 mg2228 days—
Modification of the effect of vitamin E supplementation on the mortality of male smokers by age and dietary vitamin C
2009 · β-carotene · men aged 50–69 years who smoked at least 5 cigarettes per day
20 mg8 years—
Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival
2009 · β-carotene · Caucasian male smokers aged 50–69 years; prostate cancer cases were analysed in this report
20 mg8 years—
No dose-dependent increase in fracture risk after long-term exposure to high doses of retinol or beta-carotene
2013 · 30 mg/day beta-carotene group · Adults previously exposed to blue asbestos; 664 females and 1,658 males across the study
30 mg2192 days—
No dose-dependent increase in fracture risk after long-term exposure to high doses of retinol or beta-carotene
2013 · 0.75 mg/day beta-carotene group · Adults previously exposed to blue asbestos; 664 females and 1,658 males across the study
750 mcg2192 days—
Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis
2013 · β-carotene alone · Finnish male smokers aged 50–69
20 mg2227 days—
Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study
2014 · β-carotene · Finnish male smokers aged 50–69 at baseline without self-reported cirrhosis
20 mg2922 days—
Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas
1995 · Beta-carotene intervention · Adults with at least one histologically confirmed colorectal adenoma that had been removed
20 mg1461 days—
Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study
1995 · beta-carotene · Male cigarette smokers aged 50–69 years
20 mg8 years—
Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial
1996 · beta carotene group · Men aged 50–69 who smoked and were free of known coronary heart disease at baseline
20 mg1716 days—
Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation
1996 · beta carotene supplementation · Men and women with mean age 63.2 years enrolled in a trial to prevent nonmelanoma skin cancer
50 mg1570 days—
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance
1996 · beta-carotene · Men aged 50–69 years who smoked at least five cigarettes daily
20 mg2227 days—
Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial
1998 · beta-carotene · Male smokers aged 50–69 years
20 mg2228 days—
Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. South African Vitamin A Study Group
1999 · vitamin A · pregnant HIV-infected women in their third trimester
30 mg—368
MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience
1999 · antioxidant vitamin supplement · Men and women aged 40–80 at elevated risk of coronary heart disease death due to prior coronary heart disease, occlusive non-coronary arterial disease, diabetes mellitus, or treated hypertension
20 mg5 years—
The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers
1999 · both AT and BC · middle-aged male smokers
20 mg——
Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers
2000 · alpha-tocopherol and beta-carotene · Men aged 50 to 69 who smoked cigarettes and had no history of stroke
20 mg6 years—
Vitamin E and beta carotene supplementation in high risk for stroke: a subgroup analysis of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
2000 · alpha tocopherol and beta carotene · Men aged 50–69 who smoked and were included in the high-risk-for-stroke subgroup analysis
20 mg6 years—
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
2001 · Antioxidants · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye
15 mg8 years—
Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13
2004 · antioxidants alone · Adults aged 55–81 years with age-related macular degeneration categories 1–4 or other AREDS ocular eligibility; participants in AMD categories 2–4 were eligible for this arm, and category 1 participants could also receive antioxidants
15 mg339 weeks—
Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study
2004 · alpha-tocopherol plus beta-carotene · men aged 50–69 who smoked
20 mg8 years—
The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements
2004 · active intervention group · Participants at high risk for lung cancer because of a history of smoking or asbestos exposure
30 mg——
Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension
2005 · Vitamin A without multivitamin · HIV-positive pregnant Tanzanian women
30 mg——
Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients
2006 · supplement arm · Head and neck cancer patients treated by radiation therapy
30 mg——
Effects of alpha-tocopherol and beta-carotene supplementation on upper aerodigestive tract cancers in a large, randomized controlled trial
2007 · alpha-tocopherol plus beta-carotene · Male smokers aged 50–69 years, free of cancer at baseline
20 mg2227 days—
Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients
2008 · supplementation · Head and neck cancer patients treated with radiation therapy; age and sex not stated
30 mg——
Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake
2008 · Vitamin E and beta-carotene · Males aged 50–69 years who smoked at baseline and had no tuberculosis diagnosis before randomisation
20 mg2228 days—
Modification of the effect of vitamin E supplementation on the mortality of male smokers by age and dietary vitamin C
2009 · vitamin E + β-carotene · men aged 50–69 years who smoked at least 5 cigarettes per day
20 mg8 years—
Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial
2009 · Factor D · Adults in Linxian, China; age and sex details not given
15 mg313 weeks—
Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival
2009 · α-tocopherol and β-carotene · Caucasian male smokers aged 50–69 years; prostate cancer cases were analysed in this report
20 mg8 years—
Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial
2009 · CARET intervention arm · Men aged 45–69 or 50–69 who were current or former heavy smokers or asbestos-exposed workers; the report analyzes male participants only
30 mg——
Sex differences in the effects of maternal vitamin supplements on mortality and morbidity among children born to HIV-infected women in Tanzania
2010 · Vitamin A plus β-carotene · HIV-infected pregnant women enrolled at 12–27 weeks’ gestation in Dar es Salaam, Tanzania; treatment continued after delivery while breastfeeding was nearly universal
30 mg——
Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis
2013 · combined β-carotene/α-tocopherol · Finnish male smokers aged 50–69
20 mg2227 days—
Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35
2013 · Antioxidants · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4)
15 mg339 weeks—
Plasma retinol and total carotenes and fracture risk after long-term supplementation with high doses of retinol
2014 · beta-carotene group · Adults aged 1990–1996 enrollment, 663 men and 335 women combined, in a cancer prevention program
30 mg2847 days—
No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38
2014 · antioxidants · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years
15 mg9 years—
Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study
2014 · α-tocopherol and β-carotene · Finnish male smokers aged 50–69 at baseline without self-reported cirrhosis
20 mg2922 days—
Vitamin E administration may decrease the incidence of pneumonia in elderly males
2016 · AT + BC (vitamin E + β-carotene) · Finnish males aged 50–69 at entry who smoked at least 5 cigarettes per day and started smoking at age 21 or older; the analysis subgroup included men who smoked 5–19 cigarettes per day and exercised at leisure at baseline
20 mg8 years—
No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18
2019 · Original AREDS formula without modification · Adults with bilateral large drusen or late AMD in one eye and large drusen in the fellow eye
15 mg5 years—
The effect of β-carotene on the mortality of male smokers is modified by smoking and by vitamins C and E: evidence against a uniform effect of nutrient
2020 · α-Tocopherol and β-carotene (AT + BC) · Male smokers aged 50–69 years who smoked at least 5 cigarettes per day at entry
20 mg2227 days—
Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study
1995 · beta-carotene and alpha-tocopherol · Male cigarette smokers aged 50–69 years
20 mg8 years—
Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer
1993 · retinol, beta-carotene, and vitamin E · Men aged 50–69 with oral leukoplakia and/or chronic esophagitis
40 mg87 weeks—
Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial
1996 · alpha tocopherol plus beta carotene group · Men aged 50–69 who smoked and were free of known coronary heart disease at baseline
20 mg1716 days—
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
1996 · active-treatment group · Smokers, former smokers, and workers exposed to asbestos; age and sex not specified
30 mg4 years—
Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial
1996 · active intervention group · Men and women at high risk of developing lung cancer
30 mg——
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance
1996 · alpha-tocopherol and beta-carotene · Men aged 50–69 years who smoked at least five cigarettes daily
20 mg2227 days—
Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial
1997 · vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C was common at baseline
6 mg2 years—
Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial
1998 · alpha-tocopherol plus beta-carotene · Male smokers aged 50–69 years
20 mg2228 days—
Beta-carotene produces sustained remissions in patients with oral leukoplakia: results of a multicenter prospective trial
1999 · Initial beta-carotene treatment · Adults with oral leukoplakia
60 mg26 weeks54
Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment
1997 · beta carotene · Fishermen and women with oral leukoplakia in Kerala, India
51.4 mg1 year46
Prevention of exercise-induced asthma by a natural isomer mixture of beta-carotene
1999 · beta-carotene · Patients with exercise-induced asthma; age and sex not reported
64 mg7 days38
Treatment with 9-cis β-carotene-rich powder in patients with retinitis pigmentosa: a randomized crossover trial
2013 · 9-cis β-carotene · Adults aged 18 years or older with retinitis pigmentosa
20 mg90 days29
Response of oral leukoplakia to beta-carotene
1990 · beta-carotene · Patients with oral leukoplakia; age and sex not reported.
30 mg26 weeks24
Effect of beta-carotene on immunological indexes in healthy male smokers
1993 · beta-carotene group (lymphocyte proliferation) · Healthy male cigarette smokers
20 mg14 weeks24
Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV-induced erythema
2003 · beta-carotene · Volunteers with skin type II
24 mg12 weeks12
The effect of alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial
1999 · beta-carotene only · Male smokers aged 50–69 with intermittent claudication
20 mg193 weeks—
Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans
2000 · Carotenoid supplement · Healthy volunteers
25 mg12 weeks—
Physical activity and the common cold in men administered vitamin E and beta-carotene
2003 · Beta-carotene only · Men aged 50–69 who smoked; common-cold risk was assessed in physically active subgroups
20 mg2227 days—
A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II
2007 · beta carotene group among newly recruited participants · Men older than 65 years; no specific condition stated
25 mg1 year—
A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II
2007 · beta carotene group among continuing participants · Men older than 65 years continuing from the Physicians' Health Study; no specific condition stated
25 mg657 days—
Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study
2009 · β-carotene group · Women aged 65 years or older in the cognitive substudy, with cardiovascular disease or at least three coronary risk factors
25 mg3249 days—
Differential effects of low-dose and high-dose beta-carotene supplementation on the signs of photoaging and type I procollagen gene expression in human skin in vivo
2010 · low-dose group · Healthy women over age 50
30 mg90 days—
Differential effects of low-dose and high-dose beta-carotene supplementation on the signs of photoaging and type I procollagen gene expression in human skin in vivo
2010 · high-dose group · Healthy women over age 50
90 mg90 days—
Short term effects of palm-tocotrienol and palm-carotenes on vascular function and cardiovascular disease risk: A randomised controlled trial
2016 · CC-60 · Men and women aged 18–70 years with type 2 diabetes, impaired fasting glucose and/or elevated waist circumference, at increased risk of impaired vascular function
21 mg8 weeks—
The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers
1993 · beta-carotene · Men and women aged 50–69 who were current smokers or had quit within the past 6 years and had a smoking history of at least 20 pack-years
30 mg548 days—
Vitamin A or beta-carotene supplementation reduces but does not eliminate maternal night blindness in Nepal
1998 · Beta-carotene · Pregnant women in rural Nepal; age range and specific condition not reported
1 mg——
"The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants
1999 · antioxidant vitamins and minerals supplementation · Women aged 35 to 60 years and men aged 45 to 60 years, without a stated condition
6 mg8 years—
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
2001 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye
15 mg8 years—
Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13
2004 · antioxidants plus zinc · Adults aged 55–81 years with AMD categories 2–4 and AREDS ocular eligibility
15 mg339 weeks—
The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals
2004 · antioxidant supplement group · French women aged 35–60 and men aged 45–60 in the general population
6 mg2739 days—
Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension
2005 · Multivitamin plus vitamin A · HIV-positive pregnant Tanzanian women
30 mg——
Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels?
2005 · daily antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years
6 mg2739 days—
[The SU.VI.MAX study, a randomized, placebo-controlled trial on the effects of antioxidant vitamins and minerals on health]
2006 · antioxidant supplementation · Middle-aged adults in the general population
6 mg2738 days—
Antioxidant supplementation increases the risk of skin cancers in women but not in men
2007 · antioxidant group · French adult women and men in a general-population primary-prevention trial
6 mg2738 days—
Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study
2010 · antioxidant supplementation · French women aged 35–60 years and men aged 45–60 years
6 mg2738 days—
Sex differences in the effects of maternal vitamin supplements on mortality and morbidity among children born to HIV-infected women in Tanzania
2010 · Multivitamins plus vitamin A and β-carotene · HIV-infected pregnant women enrolled at 12–27 weeks’ gestation in Dar es Salaam, Tanzania; treatment continued after delivery while breastfeeding was nearly universal
30 mg——
Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35
2013 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4)
15 mg339 weeks—
No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38
2014 · antioxidants plus zinc · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years
15 mg9 years—
Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer
1993 · riboflavin plus retinol, beta-carotene, and vitamin E · Men aged 50–69 with oral leukoplakia and/or chronic esophagitis
40 mg87 weeks—
Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial
1997 · combination of trace elements and vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C, zinc and selenium were common at baseline
6 mg2 years—
Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants
1998 · active medication · Adults with colorectal polyps; age range and sex not stated
15 mg3 years—
Efficacy of Natural β-Carotene Chewable Tablets Derived from Banana (Musa AA) Pulp in Reducing UV-Induced Skin Erythema
2024 · tested chewable tablet (TCT) group · Healthy Thai males aged 35–50 years
8 mg16 weeks20
Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV-induced erythema
2003 · carotenoid mix · Volunteers with skin type II
8 mg12 weeks12
Acute effects of ozone on pulmonary function of cyclists receiving antioxidant supplements
1998 · supplementation group · Amateur cyclists; age and sex not reported; no condition stated
15 mg90 days12
The effect of alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial
1999 · alpha-tocopherol plus beta-carotene · Male smokers aged 50–69 with intermittent claudication
20 mg193 weeks—
Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans
2000 · Carotenoid supplement plus vitamin E · Healthy volunteers
25 mg12 weeks—
Effects of vitamin A supplementation during pregnancy and early lactation on body weight of South African HIV-infected women
2001 · Pregnancy supplementation · HIV-seropositive pregnant women aged not stated, enrolled at 28–32 weeks gestation
30 mg——
The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract
2002 · vitamin group · Adult American and English outpatients with early age-related cataract
18 mg3 years—
Physical activity and the common cold in men administered vitamin E and beta-carotene
2003 · Vitamin E and beta-carotene · Men aged 50–69 who smoked; common-cold risk was assessed in physically active subgroups
20 mg2227 days—
Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients
2005 · supplement arm · Head and neck cancer patients receiving radiation therapy; age and sex not stated
30 mg3 years—
The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers
1993 · retinol plus beta-carotene · Men and women aged 50–69 who were current smokers or had quit within the past 6 years and had a smoking history of at least 20 pack-years
30 mg548 days—
Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone
1998 · supplement group · Mexico City street workers exposed to high ozone levels; age and sex not stated
15 mg26 weeks—
9-cis beta-carotene-rich powder of the alga Dunaliella bardawil increases plasma HDL-cholesterol in fibrate-treated patients
2006 · Dunaliella capsules, first trial · Fibrate-treated men with plasma HDL-cholesterol below 40 mg/dl
60 mg6 weeks20
[Study of the antioxidant drug "Karinat" in patients with chronic atrophic gastritis]
2004 · Karinat · Patients with chronic multifocal atrophic gastritis
5 mg26 weeks34
[Study of an antioxidant dietary supplement "Karinat" in patients with benign breast disease]
2004 · Karinat · Patients with benign breast disease, including mastopathy
5 mg26 weeks33
Increased vitamin plasma levels in Swedish military personnel treated with nutrients prior to automatic weapon training
2011 · Nutrients (active treatment) · Normally hearing Swedish military personnel, officers and military academy trainees, ages 18 and older, undergoing weapons training
18 mg2 days31
Adjunctive daily supplementation with encapsulated fruit, vegetable and berry juice powder concentrates and clinical periodontal outcomes: a double-blind RCT
2012 · Test 1 – Six capsules daily containing the total equivalent of four FV capsules, and two placebo capsules · Men and women aged 30–60 with chronic periodontitis; medically healthy and non-smokers
7.5 mg274 days20
Adjunctive daily supplementation with encapsulated fruit, vegetable and berry juice powder concentrates and clinical periodontal outcomes: a double-blind RCT
2012 · Test 2 – Six FVB capsules daily · Men and women aged 30–60 with chronic periodontitis; medically healthy and non-smokers
7.5 mg274 days20
The effects of antioxidant vitamin supplementation on expiratory flow rates at rest and during exercise
2015 · antioxidant vitamin supplementation (AVS) · healthy nonsmoking adults, 5 men and 5 women, consuming fewer than 5 servings of fruit and vegetables per day
15,000 IU4 weeks10
Changes in ventilatory threshold at high altitude: effect of antioxidants
2006 · antioxidant (AO) supplement group · Physically fit males aged 25 ± 5 years exposed to high altitude at 4300 m
12 mg5 weeks—
French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial
2011 · antioxidant supplementation · French adults aged 45–60 years enrolled in the SU.VI.MAX study
6 mg2922 days—
Combination oral antioxidant supplementation reduces blood pressure
1997 · antioxidants · Hypertensive and normotensive adult outpatients; 21 were attending for hypertension treatment and 17 were normotensive outpatients with minor gastrointestinal complaints.
30 mg8 weeks—
Determinants of increase in plasma concentration of beta-carotene after chronic oral supplementation. The Skin Cancer Prevention Study Group
1991 · subjects receiving oral supplementation · Adults; sex and health conditions not specified
50 mg1 year582
Effect of supplemental beta-carotene on plasma concentrations of carotenoids, retinol, and alpha-tocopherol in humans
1998 · supplemental beta-carotene · men and women with early-stage cancer of the oral cavity, pharynx, or larynx who had been cured
50 mg5 years259
Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
1997 · receiving supplemental beta-carotene · Men aged 58–76 years from the metropolitan Helsinki study center
20 mg2446 days237
Maternal vitamin A or beta-carotene supplementation in lactating bangladeshi women benefits mothers and infants but does not prevent subclinical deficiency
1999 · beta-carotene · Lactating women in Bangladesh, 1–3 weeks postpartum
7.8 mg270 days73
Low-dose beta-carotene supplementation and deworming improve serum vitamin A and beta-carotene concentrations in preschool children of Bangladesh
2010 · Group III (β-carotene + placebo) · Preschool children aged 24–60 months, both sexes, infected with Ascaris lumbricoides
1.2 mg26 weeks58
Effects of 4 y of oral supplementation with beta-carotene on serum concentrations of retinol, tocopherol, and five carotenoids
1997 · 25 mg beta-carotene/d · People enrolled in a clinical trial intended to prevent colonic adenomas; age and sex not specified
25 mg1461 days54
Low-dose beta-carotene supplementation and deworming improve serum vitamin A and beta-carotene concentrations in preschool children of Bangladesh
2010 · Group I (albendazole + β-carotene) · Preschool children aged 24–60 months, both sexes, infected with Ascaris lumbricoides
1.2 mg26 weeks52
Increase in serum beta-carotene following dark green leafy vegetable supplementation in Mebendazole-treated school children in Bangladesh
2001 · DGLV group · Children aged 8–12 years in Bangladesh treated for Ascaris lumbricoides
4.4 mg6 weeks37
Increase in serum beta-carotene following dark green leafy vegetable supplementation in Mebendazole-treated school children in Bangladesh
2001 · Sweet pumpkin group · Children aged 8–12 years in Bangladesh treated for Ascaris lumbricoides
1.5 mg6 weeks36
The effect of beta-carotene supplementation on the immune function of blood monocytes from healthy male nonsmokers
1997 · beta-carotene · healthy adult male nonsmokers
15 mg26 days25
Effects of three-month oral supplementation of beta-carotene and vitamin C on serum concentrations of carotenoids and vitamins in middle-aged subjects: a pilot study for a randomized controlled trial to prevent gastric cancer in high-risk Japanese population
2000 · Low-dose beta-carotene group · Adults aged 40–69 with chronic atrophic gastritis
3 mg90 days19
Effects of three-month oral supplementation of beta-carotene and vitamin C on serum concentrations of carotenoids and vitamins in middle-aged subjects: a pilot study for a randomized controlled trial to prevent gastric cancer in high-risk Japanese population
2000 · High-dose beta-carotene group · Adults aged 40–69 with chronic atrophic gastritis
30 mg90 days18
Low β-carotene bioaccessibility and bioavailability from high fat, dairy-based meal
2024 · β-carotene with placebo · Healthy men aged 18–45 years
15 mg1 day12
Gastric acidity influences the blood response to a beta-carotene dose in humans
1996 · beta-carotene dose under crossover gastric-pH conditions · 12 normal adults, 23–68 years, 5 women and 7 men
120 mg1 day12
Beta-carotene's effects on serum lipoproteins and immunologic indices in humans
1991 · 15 mg/day beta-carotene group · Healthy humans; age and sex not specified
15 mg30 days10
Beta-carotene's effects on serum lipoproteins and immunologic indices in humans
1991 · 45 mg/day beta-carotene group · Healthy humans; age and sex not specified
45 mg30 days10
Beta-carotene's effects on serum lipoproteins and immunologic indices in humans
1991 · 180 mg/day beta-carotene group · Healthy humans; age and sex not specified
180 mg30 days10
Beta-carotene's effects on serum lipoproteins and immunologic indices in humans
1991 · 300 mg/day beta-carotene group · Healthy humans; age and sex not specified
300 mg30 days10
Biofortified cassava increases β-carotene and vitamin A concentrations in the TAG-rich plasma layer of American women
2013 · Biofortified cassava porridge with added oil · Healthy, well-nourished American adult women
2 mg1 day10
Biofortified cassava increases β-carotene and vitamin A concentrations in the TAG-rich plasma layer of American women
2013 · Biofortified cassava porridge without added oil · Healthy, well-nourished American adult women
2 mg1 day10
Ingestion by men of a combined dose of beta-carotene and lycopene does not affect the absorption of beta-carotene but improves that of lycopene
1997 · all-trans beta-carotene dose · 10 healthy men
60 mg4 weeks10
Beta-carotene conversion to vitamin A decreases as the dietary dose increases in humans
2010 · 20-mg dose · Seven adult volunteers: 4 men and 3 women; no condition stated
20 mg1 day7
Beta-carotene conversion to vitamin A decreases as the dietary dose increases in humans
2010 · 40-mg dose · Seven adult volunteers: 4 men and 3 women; no condition stated
40 mg1 day7
Plasma and buccal mucosal cell response to short-term supplementation with all trans-beta-carotene and lycopene in human volunteers
2003 · 15 mg beta-carotene group · Human volunteers with no stated condition
15 mg7 days6
Plasma and buccal mucosal cell response to short-term supplementation with all trans-beta-carotene and lycopene in human volunteers
2003 · 30 mg beta-carotene group · Human volunteers with no stated condition
30 mg7 days6
Plasma concentration response to drinks containing beta-carotene as carrot juice or formulated as a water dispersible powder
2002 · Carrot juice-based drink, 6 mg/d beta-carotene · Volunteers; age, sex, and health status not reported
6 mg6 weeks4
Plasma concentration response to drinks containing beta-carotene as carrot juice or formulated as a water dispersible powder
2002 · Carrot juice-based drink, 18 mg/d beta-carotene · Volunteers; age, sex, and health status not reported
18 mg6 weeks4
Plasma concentration response to drinks containing beta-carotene as carrot juice or formulated as a water dispersible powder
2002 · Water-dispersible beta-carotene powder drink, 7.2 mg/d · Volunteers; age, sex, and health status not reported
7.2 mg6 weeks4
Plasma concentration response to drinks containing beta-carotene as carrot juice or formulated as a water dispersible powder
2002 · Water-dispersible beta-carotene powder drink, 21.6 mg/d · Volunteers; age, sex, and health status not reported
21.6 mg6 weeks4
Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis
2001 · high dose supplementation · Patients with cystic fibrosis; age and sex not specified
1 mg/kg90 days—
Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis
2001 · low dose supplementation · Patients with cystic fibrosis; age and sex not specified
10 mg90 days—
Supplementing lactating women with puréed papaya and grated carrots improved vitamin A status in a placebo-controlled trial
2001 · beta-carotene group · Lactating women with infants aged 2–12 months in Zimbabwe
6 mg60 days—
Circulating levels of retinol, tocopherol and carotenoid in Nepali pregnant and postpartum women following long-term beta-carotene and vitamin A supplementation
2001 · beta-carotene · Pregnant and postpartum Nepali women
6 mg——
A European multicentre, placebo-controlled supplementation study with alpha-tocopherol, carotene-rich palm oil, lutein or lycopene: analysis of serum responses
2002 · alpha- and beta-carotene (carotene-rich palm oil) · Healthy men and women aged 25–45 years from five European regions
15 mg——
Accumulation and interactions of beta-carotene and alpha-tocopherol in patients with adenomatous polyps
2002 · natural BC · Volunteers with colonic adenomatous polyps; age and sex not reported
25,000 IU43 days—
Carotenoid composition of human milk during the first month postpartum and the response to beta-carotene supplementation
2002 · beta-carotene · Healthy, well-nourished women aged 19–39 years who were breastfeeding, days 4–32 postpartum
30 mg4 weeks—
Redistribution of vitamin A after iron supplementation in Indonesian infants
2003 · 2.4 mg beta-carotene · Indonesian infants aged 4 months
2.4 mg26 weeks—
Red palm oil supplementation: a feasible diet-based approach to improve the vitamin A status of pregnant women and their infants
2003 · experimental group (red palm oil) · Pregnant women recruited at 16 to 24 weeks of gestation
2.4 mg8 weeks—
Serum beta-carotene before and after beta-carotene supplementation
1992 · beta-carotene group · Men aged 30–69 years; no condition stated
20 mg60 days—
Reduction in plasma or skin alpha-tocopherol concentration with long-term oral administration of beta-carotene in humans and mice
1992 · 15 mg beta-carotene group · Normal human subjects; age and sex not reported
15 mg270 days—
Reduction in plasma or skin alpha-tocopherol concentration with long-term oral administration of beta-carotene in humans and mice
1992 · 30 mg beta-carotene group · Normal human subjects; age and sex not reported
30 mg270 days—
Reduction in plasma or skin alpha-tocopherol concentration with long-term oral administration of beta-carotene in humans and mice
1992 · 45 mg beta-carotene group · Normal human subjects; age and sex not reported
45 mg270 days—
Reduction in plasma or skin alpha-tocopherol concentration with long-term oral administration of beta-carotene in humans and mice
1992 · 60 mg beta-carotene group · Normal human subjects; age and sex not reported
60 mg270 days—
Biofortified yellow cassava and vitamin A status of Kenyan children: a randomized controlled trial
2016 · β-carotene supplement group · Children aged 5–13 years with marginal vitamin A status
1.05 mg130 days—
Skin lycopene is destroyed preferentially over beta-carotene during ultraviolet irradiation in humans
1995 · beta-carotene group · healthy women
120 mg1 day—
Changes in serum carotenoids in subjects with colorectal adenomas after 24 mo of beta-carotene supplementation. Australian Polyp Prevention Project Investigators
1994 · beta-carotene · Adults with colorectal adenomas; 139 men and 85 women were enrolled, but arm-specific age and sex counts are not reported.
20 mg2 years—
Carotenoid and tocopherol concentrations in plasma, peripheral blood mononuclear cells, and red blood cells after long-term beta-carotene supplementation in men
1996 · 50 mg beta-carotene alone · Adult male physicians from the Boston area; no diagnosed condition stated
25 mg438 days—
Carotenoid and tocopherol concentrations in plasma, peripheral blood mononuclear cells, and red blood cells after long-term beta-carotene supplementation in men
1996 · both (aspirin and beta-carotene) · Adult male physicians from the Boston area; no diagnosed condition stated
25 mg438 days—
Beta-carotene-induced enhancement of natural killer cell activity in elderly men: an investigation of the role of cytokines
1998 · beta-carotene group · Men aged 65–88 years (mean age 73)
25 mg438 days—
Beta-carotene concentration in buccal mucosal cells with and without dysplastic oral leukoplakia after long-term beta-carotene supplementation in male smokers
1998 · beta-carotene · Male smokers in the Alpha-Tocopherol, Beta Carotene Cancer Prevention Study; age and health conditions not specified
20 mg——
Decreased excretion of thioethers in urine of smokers after the use of beta-carotene
1992 · beta-carotene group · Smokers; age and sex not reported
20 mg14 weeks62
The influence of beta-carotene on homocysteine level and oxidative stress in lead-exposed workers
2014 · beta-carotene group · Healthy male workers chronically exposed to lead
10 mg12 weeks33
No effect of beta-carotene supplementation on plasma lipoproteins in healthy smokers
1994 · beta-carotene group · healthy male cigarette smokers
20 mg14 weeks25
Effect of beta-carotene on immunological indexes in healthy male smokers
1993 · beta-carotene group (lymphocyte subsets) · Healthy male cigarette smokers
20 mg14 weeks21
Beta-carotene in HIV infection
1993 · beta-carotene · HIV-seropositive patients
180 mg4 weeks21
Dietary supplementation of a natural isomer mixture of beta-carotene inhibits oxidation of LDL derived from patients with diabetes mellitus
2000 · beta-carotene supplementation · Adults with long-standing non-insulin-dependent diabetes mellitus; age range and sex not specified
60 mg3 weeks20
Effect of the antioxidants selenium and beta-carotene on HIV-related endothelium dysfunction
1998 · beta-carotene · HIV-seropositive subjects
60 mg1 year11
Effects of beta-carotene repletion on beta-carotene absorption, lipid peroxidation, and neutrophil superoxide formation in young men
1990 · 120 mg daily group · Young men aged 18–30 years on a carotenoid-free liquid diet
120 mg4 weeks8
Effect of a single bout of exercise and beta-carotene supplementation on the urinary excretion of 8-hydroxy-deoxyguanosine in humans
1997 · beta-carotene supplement group · Healthy nonsmoking men, 19–22 years old, untrained
30 mg30 days8
Effects of beta-carotene repletion on beta-carotene absorption, lipid peroxidation, and neutrophil superoxide formation in young men
1990 · 15 mg daily group · Young men aged 18–30 years on a carotenoid-free liquid diet
15 mg4 weeks7
Beta-carotene supplementation increases antioxidant capacity of plasma in older women
1994 · beta-carotene · Healthy women aged 62–80 years
90 mg3 weeks6
The effect of a low carotenoid diet on malondialdehyde-thiobarbituric acid (MDA-TBA) concentrations in women: a placebo-controlled double-blind study
1998 · Group C (control group) · Pre-menopausal women
500 mcg100 days5
The effect of a low carotenoid diet on malondialdehyde-thiobarbituric acid (MDA-TBA) concentrations in women: a placebo-controlled double-blind study
1998 · Group P (placebo group), days 60 to 100 · Pre-menopausal women
500 mcg40 days4
Lipoprotein carotenoid profiles and the susceptibility of low density lipoprotein to oxidative modification in healthy elderly volunteers
2000 · Carotene group · Healthy adults aged 65 years or older
11.9 mg12 weeks—
Modification of lymphocyte DNA damage by carotenoid supplementation in postmenopausal women
2006 · beta-carotene · Healthy, nonsmoking postmenopausal women aged 50–70 years
12 mg8 weeks—
Investigation of the effects of oral administration of vitamin E and beta-carotene on the chemiluminescence responses and the frequency of sister chromatid exchanges in circulating leukocytes from cigarette smokers
1990 · Group 2 · Asymptomatic cigarette smokers; age and sex not specified
40 mg6 weeks—
Limited appearance of apocarotenoids is observed in plasma after consumption of tomato juices: a randomized human clinical trial
2018 · High-β-carotene tomato juice · Healthy subjects; age and sex not specified
30.4 mg4 weeks—
Effect of beta-carotene supplementation on indices of colonic cell proliferation
1995 · beta-carotene · Adults with a history of colonic polyps or prior colon cancer; mean ages 59.6 and 67.2 years, respectively; men and women
30 mg90 days—
Lack of effects of beta-carotene on lipids and sex steroid hormones in hyperlipidemics
1994 · beta-carotene, hyperlipidemic patients · Adults with Type IIa or IIb hyperlipidemia; age range and sex not stated
300 mg30 days—
Lack of effects of beta-carotene on lipids and sex steroid hormones in hyperlipidemics
1994 · beta-carotene, healthy subjects · Healthy adults; age range and sex not stated
300 mg30 days—
Effects of beta-carotene supplementation on lipid peroxidation in humans
1994 · beta-carotene group, smokers · Smokers; age and sex not reported
20 mg4 weeks—
Effects of beta-carotene supplementation on lipid peroxidation in humans
1994 · beta-carotene group, nonsmokers · Nonsmokers; age and sex not reported
20 mg4 weeks—
Natural killer cell activity in elderly men is enhanced by beta-carotene supplementation
1996 · beta-carotene-supplemented group · Men aged 51–86 years; 38 were middle-aged (51–64) and 21 were elderly (65–86)
25 mg——
The influence of antioxidant nutrients on platelet function in healthy volunteers
1997 · beta-carotene · Healthy volunteers aged 20–50 years
15 mg8 weeks—
Enhanced plasma level of lipid peroxidation in Iranians could be improved by antioxidants supplementation
1997 · beta-carotene and placebo for alpha-tocopherol · Male medical students; age not reported; no condition reported
30 mg10 weeks—
Immunomodulatory effect of beta-carotene on T lymphocyte subsets in patients with resected colonic polyps and cancer
1997 · beta-carotene · Patients with previous adenomatous colonic polyps or colon cancer
30 mg90 days—
Bioefficacy of beta-carotene dissolved in oil studied in children in Indonesia
2001 · beta-carotene and retinyl palmitate capsules · Indonesian children aged 8–11 years
160 mcg10 weeks35
Supplementation with antioxidants prior to bone marrow transplantation
1997 · BMT(+) · Bone marrow transplant patients receiving conditioning therapy
45 mg3 weeks16
Carotenoid absorption in humans consuming tomato sauces obtained from tangerine or high-beta-carotene varieties of tomatoes
2007 · High-beta-carotene sauce group · Healthy adults, 6 male and 6 female; age not reported
17 mg1 day12
Low β-carotene bioaccessibility and bioavailability from high fat, dairy-based meal
2024 · β-carotene with iron · Healthy men aged 18–45 years
15 mg1 day12
Low β-carotene bioaccessibility and bioavailability from high fat, dairy-based meal
2024 · β-carotene with zinc · Healthy men aged 18–45 years
15 mg1 day12
Effect of supplementation with beta-carotene and vitamin A on lung nutrient levels
1998 · active arm · 21 men recruited to a lung nutrient biomarker study within CARET; age and underlying risk condition not specified
30 mg26 weeks10
GLV supplements increased plasma beta-carotene, vitamin C, zinc and hemoglobin in young healthy adults
2006 · standard meal with tablets · Young healthy adults; sex and age range not reported
10 mg1 day4
Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function
2000 · CF supplementation group · Patients with cystic fibrosis, aged 12.8 ± 6.3 years
1 mg/kg24 weeks—
Accumulation and interactions of beta-carotene and alpha-tocopherol in patients with adenomatous polyps
2002 · combination BC/VE · Volunteers with colonic adenomatous polyps; age and sex not reported
25,000 IU43 days—
Zinc plus beta-carotene supplementation of pregnant women is superior to beta-carotene supplementation alone in improving vitamin A status in both mothers and infants
2004 · beta-carotene · Pregnant women; age and specific condition not stated
4.5 mg——
Effect of vitamin supplementation on breast milk concentrations of retinol, carotenoids and tocopherols in HIV-infected Tanzanian women
2009 · vitamin A and β-carotene (VA+BC) · HIV-infected pregnant women enrolled at 12–27 weeks of gestation in Dar es Salaam, Tanzania; women breastfeeding postpartum
30 mg——
Antioxidants, Helicobacter pylori and stomach cancer in Venezuela
1996 · Treatment 1 · People with precancerous stomach lesions, including chronic gastritis, chronic atrophic gastritis, intestinal metaplasia or dysplasia; age and sex not specified
18 mg7 days—
Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network
1996 · V (vitamins) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized
6 mg26 weeks—
Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters
1997 · vitamin group · Hospitalized adults older than 65 years; baseline vitamin C deficiency was common
6 mg2 years—
Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX
1997 · vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care
6 mg1 year—
Beta-carotene concentration in buccal mucosal cells with and without dysplastic oral leukoplakia after long-term beta-carotene supplementation in male smokers
1998 · beta-carotene plus alpha-tocopherol · Male smokers in the Alpha-Tocopherol, Beta Carotene Cancer Prevention Study; age and health conditions not specified
20 mg——
Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial
2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception
720 mcg—870
Changes in cholesterol and triglyceride concentrations in the Vanguard population of the Carotene and Retinol Efficacy Trial (CARET)
2005 · Active intervention group (beta-carotene and/or retinol) · Adults in CARET Vanguard, including asbestos-exposed participants and smokers
30 mg2557 days863
Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial
2023 · control · Women planning pregnancy; generally healthy, recruited before conception
720 mcg—859
Effects of Multivitamin, Multimineral and Phytonutrient Supplementation on Nutrient Status and Biomarkers of Heart Health Risk in a Russian Population: A Randomized, Double Blind, Placebo Controlled Study
2018 · VMP (Nutrilite Double X™) · Generally healthy adults aged 40–70 years in Moscow with low habitual recommended-food intake (recommended food score <12), predominantly women; no chronic diseases
3 mg8 weeks60
Effects of beta-carotene fortified synbiotic food on metabolic control of patients with type 2 diabetes mellitus: A double-blind randomized cross-over controlled clinical trial
2016 · beta-carotene fortified synbiotic food · Patients with type 2 diabetes mellitus
150 mg6 weeks51
[Effects of vitamins E, C and beta-carotene on DNA damage]
1999 · trial group · Healthy men aged 50–59 years
25 mg20 weeks50
Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial
2021 · Liposomal group · Patients aged 16–55 years with pancreatic-insufficient cystic fibrosis
4 mg90 days25
Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial
2021 · Cyclodextrin group · Patients aged 16–55 years with pancreatic-insufficient cystic fibrosis
4 mg90 days25
Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial
2021 · MCT group · Patients aged 16–55 years with pancreatic-insufficient cystic fibrosis
4 mg90 days25
Paraoxonase 1 Q192R (PON1-192) polymorphism is associated with reduced lipid peroxidation in healthy young men on a low-carotenoid diet supplemented with tomato juice
2005 · tomato juice · healthy, non-smoking young men on a low-carotenoid diet
1.6 mg2 weeks22
Paraoxonase 1 Q192R (PON1-192) polymorphism is associated with reduced lipid peroxidation in healthy young men on a low-carotenoid diet supplemented with tomato juice
2005 · carrot juice · healthy, non-smoking young men on a low-carotenoid diet
27.1 mg2 weeks22
Antioxidant vitamins and low-density-lipoprotein oxidation
1993 · antioxidant supplementation · Adults; ages and health conditions not stated
18 mg26 weeks22
Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial
1992 · active treatment · Patients with recurrent non-gallstone pancreatitis
9,000 IU10 weeks20
Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study
2014 · softgel half-dose (single softgel) · Healthy adults aged 18–45 years, women and men
8.6 mg1 day15
Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study
2014 · softgel full-dose (two softgels) · Healthy adults aged 18–45 years, women and men
17.2 mg1 day15
Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study
2014 · tablet full-dose (four tablets) · Healthy adults aged 18–45 years, women and men
17.2 mg1 day15
Antioxidant supplementation enhances neutrophil oxidative burst in trained runners following prolonged exercise
2003 · antioxidant vitamin supplement · Healthy trained endurance runners; 6 men and 6 women, mean age 30.1 years
18 mg7 days12
Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation
1993 · combined antioxidant therapy · adult male subjects; age and health condition not specified
30 mg90 days12
Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients
2005 · antioxidant supplementation phase · renal transplant recipients taking cyclosporin A; age and sex not reported
6 mg26 weeks10
Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial
1999 · Antioxidant vitamins · Men aged 30–49 with plasma homocysteine concentration ≥8.34 μmol/L
9 mg8 weeks—
The effect of antenatal vitamin A and beta-carotene supplementation on gut integrity of infants of HIV-infected South African women
2001 · vitamin A group · HIV-infected pregnant South African women; age not stated
30 mg——
Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study
2001 · Antioxidant supplementation group · Women aged 35–60 years and men aged 45–60 years in France, general population
6 mg2 years—
Diet supplementation with vitamin E, vitamin C and beta-carotene cocktail enhances basal neutrophil antioxidant enzymes in athletes
2002 · antioxidant-supplemented group · Sportsmen; age and health condition not specified
30 mg90 days—
Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function
2003 · group B [high dose of supplement] · Patients with cystic fibrosis; age and sex not specified
25 mg8 weeks—
Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation
2003 · micronutrient supplement group · Alcohol-dependent patients aged 20 to 60 years without severe liver disease, hospitalized for alcohol rehabilitation
6 mg3 weeks—
Antioxidant diet supplementation influences blood iron status in endurance athletes
2004 · antioxidant supplemented · Amateur trained male endurance athletes
30 mg90 days—
Zinc plus beta-carotene supplementation of pregnant women is superior to beta-carotene supplementation alone in improving vitamin A status in both mothers and infants
2004 · beta-carotene plus zinc · Pregnant women; age and specific condition not stated
4.5 mg——
Response of blood cell antioxidant enzyme defences to antioxidant diet supplementation and to intense exercise
2006 · antioxidant supplemented · Amateur trained male athletes; age and health condition not specified
30 mg90 days—
Modification of lymphocyte DNA damage by carotenoid supplementation in postmenopausal women
2006 · mixed carotenoids · Healthy, nonsmoking postmenopausal women aged 50–70 years
4 mg8 weeks—
Antioxidant supplementation lowers exercise-induced oxidative stress in young overweight adults
2006 · overweight adults receiving antioxidant treatment · overweight adults aged 18–30 years
10 mg8 weeks—
Antioxidant supplementation lowers exercise-induced oxidative stress in young overweight adults
2006 · normal-weight adults receiving antioxidant treatment · normal-weight adults aged 18–30 years
10 mg8 weeks—
Multivitamin-mineral supplementation prevents lipid peroxidation during "the Marathon des Sables"
2007 · Supplemented group · Athletes participating in the Marathon des Sables; age and sex not specified
4.8 mg4 weeks—
Antioxidant diet supplementation enhances aerobic performance in amateur sportsmen
2007 · antioxidant-supplemented group · Amateur male athletes; age and health condition not stated
30 mg90 days—
Effect of vitamin supplementation on breast milk concentrations of retinol, carotenoids and tocopherols in HIV-infected Tanzanian women
2009 · multivitamins including vitamin A and β-carotene · HIV-infected pregnant women enrolled at 12–27 weeks of gestation in Dar es Salaam, Tanzania; women breastfeeding postpartum
30 mg——
[Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person]
2008 · Group 1 · Adults aged 60–75 years; elderly participants
16.7 mg16 weeks—
[Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person]
2008 · Group 2 · Adults aged 60–75 years; elderly participants
8.4 mg16 weeks—
[Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person]
2008 · Group 3 · Adults aged 60–75 years; elderly participants
5.6 mg16 weeks—
Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults
2009 · Normal-weight antioxidant-treated (N-AOX) · Apparently healthy men and women aged 18–30 years with BMI <25 kg/m²
10 mg8 weeks—
Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults
2009 · Overweight antioxidant-treated (O-AOX) · Apparently healthy men and women aged 18–30 years with BMI ≥25 kg/m²
10 mg8 weeks—
Multinutrient-fortified juices improve vitamin D and vitamin E status in children: a randomized controlled trial
2014 · CaDEA · Children aged approximately 8 years
2,000 IU12 weeks—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS antioxidants only · Adults aged 55–80 with early or more advanced age-related macular degeneration
15 mg5 years—
The effect of long-term beta-carotene and vitamin A administration on serum concentrations of alpha-tocopherol
1994 · beta-carotene and vitamin A active agents · Participants enrolled in the Carotene and Retinol Efficacy Trial; age, sex, and health condition not specified
30 mg6 years—
Effects of an antioxidant vitamin mixture on lipid peroxidation at rest and postexercise
1993 · antioxidant vitamin group · Young healthy males, mean age 25.0 years
30 mg6 weeks—
Antioxidants, Helicobacter pylori and stomach cancer in Venezuela
1996 · Treatment 2 · People with precancerous stomach lesions, including chronic gastritis, chronic atrophic gastritis, intestinal metaplasia or dysplasia; age and sex not specified
15 mg7 days—
Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network
1996 · VT (vitamins associated with trace elements) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized
6 mg26 weeks—
Enhanced plasma level of lipid peroxidation in Iranians could be improved by antioxidants supplementation
1997 · beta-carotene plus alpha-tocopherol · Male medical students; age not reported; no condition reported
30 mg10 weeks—
Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease
1997 · mid-dose · Patients with established cardiovascular disease
12 mg12 weeks—
Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease
1997 · high dose · Patients with established cardiovascular disease
24 mg12 weeks—
Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters
1997 · mineral and vitamin group · Hospitalized adults older than 65 years; baseline deficiencies of vitamin C, zinc and selenium were common
6 mg2 years—
Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX
1997 · trace elements associated with vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care
6 mg1 year—
Effects of supplementation with a combination of antioxidant vitamins and trace elements, at nutritional doses, on biochemical indicators and markers of the antioxidant system in adult subjects
1998 · supplementation group · Adult men aged 45–60 years and women aged 35–60 years
6 mg26 weeks—
Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers
1998 · antioxidants without n-3 fatty acids · adult male smokers with hyperlipidaemia
15 mg6 weeks—
Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3)
1996 · intervention group · Patients with suspected acute myocardial infarction; age and sex not stated
25 mg4 weeks63
Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk
2004 · antioxidant-supplemented group · Middle-aged men: myocardial infarction survivors younger than 50 and healthy controls
6 mg12 weeks53
Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people
2011 · Y2 · Healthy young adults aged 18–22 years
1.5 mg60 days45
Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people
2011 · O2 · Healthy older adults aged 60–75 years
1.5 mg60 days45
[Metabolic estimation of efficiency of vitamin and mineral complexes in qualified athletes]
2021 · main group · Professional athletes in cyclic sports; age and sex not stated
1.5 mg30 days42
[Effect of multiple micronutrients supplementation on anti-oxidative activity and oxidized DNA damage of lymphocytes in children]
2005 · supplement group · Chinese children aged 9–11 years, described as healthy and living in a rural area
1 mg8 weeks41
Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people
2011 · C2 · Healthy children aged 8–10 years
1 mg60 days40
Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status
1991 · antioxidant-supplemented men · Men with low antioxidant status
27 mg150 days39
Dietary supplementation with a natural carotenoid mixture decreases oxidative stress
2003 · Fish oil plus natural carotenoid mixture · Healthy, free-living, nonsmoking adults
6 mg3 weeks31
Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled clinical trial
1994 · supplemented group · Healthy men aged 30–58 years who smoked 15–40 cigarettes per day
30 mg90 days20
Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial
1999 · B vitamins with antioxidant vitamins · Men aged 30–49 with plasma homocysteine concentration ≥8.34 μmol/L
9 mg8 weeks—
Effect of antioxidant supplementation on urine and blood markers of oxidative stress during extended moderate-altitude training
1999 · antioxidant supplement (S) group · US Marine Corps volunteers undergoing 14 days of winter training at approximately 2700 m
20,000 IU2 weeks—
Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study
2005 · antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years
6 mg2738 days—
Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration
2007 · antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration
15 mg2433 days—
Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial
2010 · antioxidant micronutrient combination · Patients with a history of sporadic colorectal adenoma; age and sex not specified
24 mg120 days—
Effects of 6 weeks of n-3 fatty acids and antioxidant mixture on lipid peroxidation at rest and postexercise
2011 · LCPUFA plus antioxidant mixture · Judoists; age and sex not reported; no diagnosed condition stated
6 mg6 weeks—
Antioxidant micronutrient supplementation increases erythrocyte membrane fluidity in adults from a rural Chinese community
2011 · A2 · Children; age range and sex not reported
1 mg60 days—
Antioxidant micronutrient supplementation increases erythrocyte membrane fluidity in adults from a rural Chinese community
2011 · B2 · Young people; age range and sex not reported
1.5 mg60 days—
Antioxidant micronutrient supplementation increases erythrocyte membrane fluidity in adults from a rural Chinese community
2011 · C2 · Elderly subjects; age range and sex not reported
1.5 mg60 days—
Tomato Phytonutrients Balance UV Response: Results from a Double-Blind, Randomized, Placebo-Controlled Study
2019 · active-supplement group · healthy volunteers; age and sex not specified
800 mcg12 weeks—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS antioxidants plus zinc · Adults aged 55–80 with early or more advanced age-related macular degeneration
15 mg5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
15 mg5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
15 mg5 years—
Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants
1997 · antioxidants · male smokers with combined hyperlipidemia
15 mg6 weeks—
Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants
1997 · omega-3 FAs and antioxidants · male smokers with combined hyperlipidemia
15 mg6 weeks—
Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers
1998 · n-3 fatty acids with antioxidants · adult male smokers with hyperlipidaemia
15 mg6 weeks—
Supplementation with antioxidants prior to bone marrow transplantation
1997 · Healthy control group · Healthy controls
45 mg3 weeks10
Redistribution of vitamin A after iron supplementation in Indonesian infants
2003 · 10 mg Zn + 2.4 mg beta-carotene · Indonesian infants aged 4 months
2.4 mg26 weeks—
Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration
2007 · antioxidants · Adults aged 55–80 with age-related macular degeneration
15 mg2433 days—
Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk
2009 · β-carotene group · Men aged 50–69 years in southwestern Finland who smoked at least five cigarettes per day
20 mg2228 days—
Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk
2009 · β-carotene plus vitamin E group · Men aged 50–69 years in southwestern Finland who smoked at least five cigarettes per day
20 mg2228 days—